Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Opioid Use Disorder (OUD) Market Growth in 2025?

In the recent past, there has been a notable acceleration in the market size of opioid use disorder (OUD). It is projected that the market, which is valued at $3.96 billion in 2024, will escalate to $4.39 billion in 2025, registering a compound annual growth rate (CAGR) of 10.9%. The growth observed in the earlier period can be traced back to factors such as high prescription rates, effective pain management techniques, strategic drug marketing, and the stigma associated with addiction.

What Is the Forecast for the Opioid Use Disorder (OUD) Market Size Through 2029?

Expectations are high for the opioid use disorder (OUD) market to experience significant expansion in the forthcoming years, with projections suggesting a growth to $6.94 billion by 2029, registering a compound annual growth rate (CAGR) of 12.1%. The anticipated growth within the forecast period can be linked to factors like regulatory measures, emphasis on alternative pain management strategies, widened scope of treatment access, and public health campaigns. Key trends emerging in the forecast period encompass advancements in treatment technology, personalized treatment techniques, the adoption of integrated care models, the establishment of community-based support schemes, and a higher degree of early intervention and prevention.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12586&type=smp

What are the Key Market Players in Opioid Use Disorder (OUD) Market and How They’re Evolving?

Major companies operating in the opioid use disorder (OUD) market include Pfizer Inc., Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Chiesi Pharmaceuticals S.p.A., Hikma Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals, Indivior Plc., Purdue Pharma L.P, Alkermes Inc., Collegium Pharmaceutical Inc., Vanda Pharmaceuticals Inc., Camurus AB, Tris Pharma Inc., Mylan NV., Orexo US Inc., Zogenix Inc., Rhodes Pharmaceuticals L.P., Omeros Corporation, Braeburn Pharmaceuticals Inc., Adapt Pharma Inc., Titan Pharmaceuticals Inc., BioDelivery Sciences International Inc., AcelRx Pharmaceuticals Inc., KemPharm Inc.

What Are the Primary Growth Drivers in the Opioid Use Disorder (OUD) Market?

The escalating cases of opioid addiction are anticipated to fuel the expansion of the opioid use disorder (OUD) market. A medical condition marked by obsessive and consistent use of opioids leading to harmful effects defines opioid addiction. These substances have the capability to generate feelings of euphoria and relieve pain, but their sustained use can lead to tolerance, necessitating larger doses to achieve the desired result, potentially resulting in opioid use disorder. For example, the Centers for Disease Control and Prevention, a health agency based in the United States, noted a surge of 4.1% in synthetic opioid drug overdosage rates in March 2024, growing from a rate of 21.8 to 22.7 between 2021 and 2022. Hence, the rising opioid addiction cases serve as a significant factor propelling the OUD market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12586&type=smp

What Are the Leading Segments in the Global Opioid Use Disorder (OUD) Industry?

The opioid use disorder (OUD) market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Methadone

2) By Route of Administration: Oral, Parenteral

3) By Age Group: 19 To 40, 41 To 60, 61 And Over

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Buprenorphine: Suboxone, Buprenorphine Tablets, Buprenorphine Film

2) By Naltrexone: Naltrexone Tablets, Vivitrol

3) By Methadone: Methadone Tablets, Methadone Oral Solution

What Are the Key Market Trends in the Opioid Use Disorder (OUD) Industry?

A significant trend in the opioid use disorder (OUD) market is product innovation. In order to maintain their industry standing, leading companies are introducing novel products. For instance, in May 2023, Brixadi (buprenorphine) extended-release injection was given the green light by the U.S. Food and Drug Administration, a federal agency based in the U.S., for the treatment of moderate to severe opioid use disorder (OUD). Brixadi comes in two dosage variations: a weekly injection for patients who began treatment with a single dose of a transmucosal buprenorphine product or those still on the medication, and a monthly option for those who are already under medication.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/opioid-use-disorder-oud-global-market-report

What Is the Regional Outlook for the Opioid Use Disorder (OUD) Market?

North America was the largest region in the opioid use disorder (OUD) market in 2024. The regions covered in the opioid use disorder (OUD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12586

This Report Delivers Insight On:

1. How big is the opioid use disorder (oud) market, and how is it changing globally?

2. Who are the major companies in the opioid use disorder (oud) market, and how are they performing?

3. What are the key opportunities and risks in the opioid use disorder (oud) market right now?

4. Which products or customer segments are growing the most in the opioid use disorder (oud) market?

5. What factors are helping or slowing down the growth of the opioid use disorder (oud) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model